Benitec Biopharma (BNTC) Gross Margin: 2019-2023
Historic Gross Margin for Benitec Biopharma (BNTC) over the last 2 years, with Jun 2023 value amounting to 100.00%.
- Benitec Biopharma's Gross Margin was N/A to 100.00% in Q2 2023 from the same period last year, while for Jun 2023 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2023, which is 1233.00% up from last year.
- According to the latest figures from Q2 2023, Benitec Biopharma's Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q1 2023.
- Benitec Biopharma's 5-year Gross Margin high stood at 100.00% for Q4 2021, and its period low was -1,800.00% during Q4 2020.
- Moreover, its 3-year median value for Gross Margin was 100.00% (2023), whereas its average is -7.14%.
- Per our database at Business Quant, Benitec Biopharma's Gross Margin plummeted by 150,260bps in 2020 and then surged by 190,000bps in 2021.
- Over the past 5 years, Benitec Biopharma's Gross Margin (Quarterly) stood at -297.40% in 2019, then slumped by 150,260bps to -1,800.00% in 2020, then soared by 190,000bps to 100.00% in 2021, then remained steady at 100.00% in 2022, then remained steady at 100.00% in 2023.
- Its Gross Margin stands at 100.00% for Q2 2023, versus 100.00% for Q1 2023 and 100.00% for Q4 2022.